Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer (Q58407764)
Jump to navigation
Jump to search
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer |
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov |
Statements
18 year
0 references